Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology

In this Backstory, we illustrate how a recent work from our multidisciplinary collaborative group identifies molecular subtypes of triple-negative breast cancer with a noninvasive radiomic pipeline. These findings appeared in the July 2022 issue of Cell Reports Medicine (https://www.cell.com/cell-re...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Guan-Hua, Xiao, Yi, Jiang, Yi-Zhou, Shao, Zhi-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Backstory
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797946/
https://www.ncbi.nlm.nih.gov/pubmed/36543098
http://dx.doi.org/10.1016/j.xcrm.2022.100808
_version_ 1784860797262888960
author Su, Guan-Hua
Xiao, Yi
Jiang, Yi-Zhou
Shao, Zhi-Ming
author_facet Su, Guan-Hua
Xiao, Yi
Jiang, Yi-Zhou
Shao, Zhi-Ming
author_sort Su, Guan-Hua
collection PubMed
description In this Backstory, we illustrate how a recent work from our multidisciplinary collaborative group identifies molecular subtypes of triple-negative breast cancer with a noninvasive radiomic pipeline. These findings appeared in the July 2022 issue of Cell Reports Medicine (https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(22)00230-0).
format Online
Article
Text
id pubmed-9797946
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-97979462022-12-30 Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology Su, Guan-Hua Xiao, Yi Jiang, Yi-Zhou Shao, Zhi-Ming Cell Rep Med Backstory In this Backstory, we illustrate how a recent work from our multidisciplinary collaborative group identifies molecular subtypes of triple-negative breast cancer with a noninvasive radiomic pipeline. These findings appeared in the July 2022 issue of Cell Reports Medicine (https://www.cell.com/cell-reports-medicine/fulltext/S2666-3791(22)00230-0). Elsevier 2022-12-20 /pmc/articles/PMC9797946/ /pubmed/36543098 http://dx.doi.org/10.1016/j.xcrm.2022.100808 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Backstory
Su, Guan-Hua
Xiao, Yi
Jiang, Yi-Zhou
Shao, Zhi-Ming
Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title_full Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title_fullStr Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title_full_unstemmed Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title_short Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
title_sort uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology
topic Backstory
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797946/
https://www.ncbi.nlm.nih.gov/pubmed/36543098
http://dx.doi.org/10.1016/j.xcrm.2022.100808
work_keys_str_mv AT suguanhua uncoveringthemolecularsubtypesoftriplenegativebreastcancerwithanoninvasiveradiomicmethodology
AT xiaoyi uncoveringthemolecularsubtypesoftriplenegativebreastcancerwithanoninvasiveradiomicmethodology
AT jiangyizhou uncoveringthemolecularsubtypesoftriplenegativebreastcancerwithanoninvasiveradiomicmethodology
AT shaozhiming uncoveringthemolecularsubtypesoftriplenegativebreastcancerwithanoninvasiveradiomicmethodology

Ejemplares similares